133 related articles for article (PubMed ID: 33757977)
1. Stomatin-Mediated Inhibition of the Akt Signaling Axis Suppresses Tumor Growth.
Rahman NIA; Sato A; Tsevelnorov K; Shimizu A; Komeno M; Ahmat Amin MKB; Molla MR; Soh JEC; Nguyen LKC; Wada A; Kawauchi A; Ogita H
Cancer Res; 2021 May; 81(9):2318-2331. PubMed ID: 33757977
[TBL] [Abstract][Full Text] [Related]
2. A Novel Inhibitor of AKT1-PDPK1 Interaction Efficiently Suppresses the Activity of AKT Pathway and Restricts Tumor Growth In Vivo.
Mäemets-Allas K; Viil J; Jaks V
Mol Cancer Ther; 2015 Nov; 14(11):2486-96. PubMed ID: 26294745
[TBL] [Abstract][Full Text] [Related]
3. Cell-to-cell contact-mediated regulation of tumor behavior in the tumor microenvironment.
Sato A; Rahman NIA; Shimizu A; Ogita H
Cancer Sci; 2021 Oct; 112(10):4005-4012. PubMed ID: 34420253
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of Akt-Pdpk1 interaction efficiently suppresses the growth of murine primary liver tumor cells.
Mäemets-Allas K; Belitškin D; Jaks V
Biochem Biophys Res Commun; 2016 May; 474(1):118-125. PubMed ID: 27103434
[TBL] [Abstract][Full Text] [Related]
5. Lemur Tyrosine Kinase-3 Suppresses Growth of Prostate Cancer Via the AKT and MAPK Signaling Pathways.
Sun P; Sun X; Zhao W; Ren M; Zhang C; Wang Z; Xu W
Cell Physiol Biochem; 2017; 42(6):2582-2592. PubMed ID: 28848113
[TBL] [Abstract][Full Text] [Related]
6. POU2F2 regulates glycolytic reprogramming and glioblastoma progression via PDPK1-dependent activation of PI3K/AKT/mTOR pathway.
Yang R; Wang M; Zhang G; Li Y; Wang L; Cui H
Cell Death Dis; 2021 Apr; 12(5):433. PubMed ID: 33931589
[TBL] [Abstract][Full Text] [Related]
7. miR‑16‑2‑3p inhibits cell proliferation and migration and induces apoptosis by targeting PDPK1 in maxillary primordium mesenchymal cells.
Han T; Wu N; Wang Y; Shen W; Zou J
Int J Mol Med; 2019 Mar; 43(3):1441-1451. PubMed ID: 30664182
[TBL] [Abstract][Full Text] [Related]
8. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
9. Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis.
Duan S; Moro L; Qu R; Simoneschi D; Cho H; Jiang S; Zhao H; Chang Q; de Stanchina E; Arbini AA; Pagano M
Cell Rep; 2021 Oct; 37(3):109870. PubMed ID: 34686346
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN/Akt axis.
Cui Z; Gao H; Yan N; Dai Y; Wang H; Wang M; Wang J; Zhang D; Sun P; Qi T; Wang Q; Kang W; Jin X
Aging (Albany NY); 2021 Apr; 13(8):12113-12128. PubMed ID: 33848262
[TBL] [Abstract][Full Text] [Related]
11. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z
BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122
[TBL] [Abstract][Full Text] [Related]
12. Phosphoinositide-dependent Kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated Kinase 3 (SGK3) for prostate cancer cell survival.
Nalairndran G; Hassan Abdul Razack A; Mai CW; Fei-Lei Chung F; Chan KK; Hii LW; Lim WM; Chung I; Leong CO
J Cell Mol Med; 2020 Oct; 24(20):12188-12198. PubMed ID: 32926495
[TBL] [Abstract][Full Text] [Related]
13. As a downstream target of the AKT pathway, NPTX1 inhibits proliferation and promotes apoptosis in hepatocellular carcinoma.
Zhao Y; Yu Y; Zhao W; You S; Feng M; Xie C; Chi X; Zhang Y; Wang X
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31113871
[TBL] [Abstract][Full Text] [Related]
14. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
Luo F; Zhao Y; Liu J
Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
[TBL] [Abstract][Full Text] [Related]
15. miR‑181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma.
Tang D; Gao W; Yang J; Liu J; Zhao J; Ge J; Chen Q; Liu B
Mol Med Rep; 2020 Nov; 22(5):3804-3812. PubMed ID: 33000209
[TBL] [Abstract][Full Text] [Related]
16. Binding of
Zhang Y; Hu B; Li Y; Deng T; Xu Y; Lei J; Zhou J
Autophagy; 2020 Sep; 16(9):1697-1710. PubMed ID: 31885313
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo.
Ni J; Cozzi P; Beretov J; Duan W; Bucci J; Graham P; Li Y
BMC Cancer; 2018 Nov; 18(1):1092. PubMed ID: 30419852
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of the Hedgehog and PDPK1-Akt pathways in the growth and migration of small-cell lung cancer.
Tang N; Hu B; Zhang Y; Chen Z; Yu R
J Int Med Res; 2021 May; 49(5):3000605211016562. PubMed ID: 34038205
[TBL] [Abstract][Full Text] [Related]
19. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
[TBL] [Abstract][Full Text] [Related]
20. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
